AMYLYX
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 15 Dec 2025)
What this means for you
Registered since 10 Sept 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88319636
- Registration number
- 5856852
- Mark type
- Stylized text
- Filed
- 28 Feb 2019
- Published for opposition
- 25 Jun 2019
- Registered
- 10 Sept 2019
- Attorney of record
- Cynthia Johnson Walden
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; pharmaceutical drug development services; testing of pharmaceuticals
Owner
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 23 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Feb 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 23 Feb 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 15 Dec 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 15 Dec 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 15 Dec 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Sept 2025 — TEAS SECTION 8 & 15 RECEIVED
- 10 Sept 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 10 Sept 2019 — REGISTERED-PRINCIPAL REGISTER
- 25 Jul 2019 — ASSIGNED TO EXAMINER
- 25 Jun 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Jun 2019 — PUBLISHED FOR OPPOSITION
- 05 Jun 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED